tyb
o7
Alector, Inc sold by Orbimed Advisors LLC: $7.4m-Jan 9
Alector is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Immuno-neurology targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. Alector is developing a broad portfolio of programs designed to functionally repair genetic mutations that cause dysfunction of the brain’s immune system and enable the rejuvenated immune cells to counteract emerging brain pathologies. The Company’s product candidates are supported by biomarkers and target genetically defined patient populations in frontotemporal dementia and Alzheimer’s disease. Alector is headquartered in South San Francisco, California.
Orbimed Healthcare Fund Mgmt
From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer and more productive lives.
We have been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations. Our team of over 80 distinguished scientific, medical, investment and other professionals manages over $13 billion across public and private company investments worldwide.
https://www.marketscreener.com/ALECTOR-INC-54379343/company/
http://www.orbimed.com/en/leadership/partners
https://www.finviz.com/insidertrading.ashx?oc=1055951&tc=7&b=2
Nike, Inc EVP Global Sports Mktg sold $11.13m-Jan 10
muh option exercise and sale. Input cost: $3.48m
net: $7.65m
https://www.finviz.com/insidertrading.ashx?oc=1418799&tc=7&b=2